PTAB Litigation Blog
  • Home
  • Cookie Policy
  • About
  • Advanced Topics
  • Contributors
  • Contacts
  • Design Patents
  • Discovery
  • District Court
  • Joinder
Select Page
PTAB Denies Joinder of IPR Petitioner That Won’t Take “Silent Understudy” Role

PTAB Denies Joinder of IPR Petitioner That Won’t Take “Silent Understudy” Role

by Cary Miller | Jul 20, 2017 | Pharmaceutical, Trial Institution

By Achim Brinker, Ph.D. and Cary Miller, Ph.D. In orders entered July 10 and 12, 2017, the PTAB instituted further inter partes review (IPR) of six Allergan Inc. (“Allergan”) patents relating to cyclosporine compositions.  Each of U.S. Patent Nos. 8,633,162,...
Product-by-Process Claims Invalid when the Process Does Not Impart Structural or Functional Differences

Product-by-Process Claims Invalid when the Process Does Not Impart Structural or Functional Differences

by Cary Miller | May 5, 2017 | Pharmaceutical

By Kunyong Yang and Cary Miller, Ph.D. The PTAB issued a final written decision in IPR2016-00006, holding claims 1–22 of U.S. Patent No. 8,497,393 (“the ’393 patent”) unpatentable under 35 U.S.C. § 102(b) and 35 U.S.C. § 103(a).  All of the claims are...
Allergan Successfully Invalidates Claims Relating to Using Botox to Treat Back Pain

Allergan Successfully Invalidates Claims Relating to Using Botox to Treat Back Pain

by Cary Miller | Apr 24, 2017 | Final Written Decisions, Pharmaceutical

By Unmesh Shah, Ph.D. and Cary Miller, Ph.D. Allergan is typically the patent holder in these types of disputes, however, it recently successfully played the role of petitioner in an IPR against 1474791 Ontario Ltd.’s U.S. Patent No. 6,806,251 covering the use of...
PTAB Invalidates Two Anacor KERYDIN® Patents

PTAB Invalidates Two Anacor KERYDIN® Patents

by Cary Miller | Mar 30, 2017 | Final Written Decisions, Pharmaceutical

By Olga Schwier, Ph.D. and Cary Miller, Ph.D. The PTAB found obvious all claims of U.S. Patent Nos. 7,582,621 and 7,767,657 in the three final written decisions issued on February 23, 2017 (IPR2015-01776, IPR2015-01780, and IPR2015-01785).  This marks another victory...
Unsuccessfully Using the Wayback Machine to Establish Status as a Printed Publication

Unsuccessfully Using the Wayback Machine to Establish Status as a Printed Publication

by Cary Miller | Mar 24, 2017 | Pharmaceutical, Prior Art Issues

By Jeff Giering, Ph.D. and Cary Miller, Ph.D. On March 6, 2017, the PTAB issued a pair of final written decisions upholding the patentability of U.S. Patent Nos. 7,932,268 (IPR2015-01836) and 8,618,135 (IPR2015-01835), in challenges filed by the Coalition for...
« Older Entries
Next Entries »

About this blog

Categories

  • 325(d) issues
  • Amendment Practice
  • CBMs
  • Claim Construction
  • Design Patents
  • Discovery
  • District Court
  • Estoppel
  • Evidentiary Issues
  • Expert Witnesses
  • Federal Circuit
  • Federal Circuit Appeal
  • Final Written Decisions
  • Joinder
  • Motions Practice
  • Other News
  • Patent Eligible Subject Matter
  • Petitions
  • PGR
  • Pharmaceutical
  • Preliminary Responses
  • Prior Art Issues
  • PTAB News
  • PTAB Trial Basics
  • Real Party in Interest
  • Request for Reconsideration
  • Standing
  • Stay
  • Time Limits
  • Trial Institution
  • Uncategorized

Archives

Links

www.jonesday.com

About Jones Day's Intellectual Property Practice

Subscribe to Jones Day publications

    • Privacy
    • X
    • RSS

    The opinions expressed are those of the authors and do not necessarily reflect the views of Jones Day or its clients. The posts and information provided are for general information purposes and are not intended to be and should not be taken as legal advice.